Bioreliance Corporation

Rockville, United StatesFEI 1122041

Bioreliance Corporation is a drug establishment in Rockville, United States, registered with the US FDA under FEI 1122041. Its registered operations are: Analytical testing. 2 EU/UK GMP certificates are matched to this site, 2 inspected within the last three years.

Sources: FDA Drug Establishments Current Registration Site (checked 2 Nov 2026); EudraGMDP; MHRA GMDP. Methodology

Registered operations

Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.

Analytical testing

GMP documents matched to this site (2)

DocumentAuthorityInspectionSource
484544-104752711
GMP certificate
Competent authority of Austria26 Mar 2026
within 3-year review window
EudraGMDP
35735
GMP certificate
Competent authority of Ireland14 Mar 2025
within 3-year review window
EudraGMDP

A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.

What this page does not show

  • Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
  • Capacity, scale, price or current availability: no regulator publishes these.
  • FDA inspection classifications for this site, which are not yet linked.

Other sites registered by the same company